METHOD FOR TREATING DIABETIC RETINOPATHY

FIELD: medicine, ophthalmology. ^ SUBSTANCE: one should daily introduce medicinal mixture consisting of lidocaine, retiling, dalargin, mildronate and lidase into orbital lymphatic area, about 8-10 procedures/course followed by discrete plasmapheresis by activating cell mass due to incubation with me...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	CHERNYKH VALERIJ VJACHESLAVOVICH, LJUBARSKIJ MIKHAIL SEMENOVICH, KOMBANTSEV EVGENIJ ALEKSANDROVICH, SMAGIN ALEKSANDR ANATOL'EVICH, BRATKO VLADIMIR IVANOVICH, LYSIKOV ANDREJ GENNAD'EVICH
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROMTHE BODY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, ophthalmology. ^ SUBSTANCE: one should daily introduce medicinal mixture consisting of lidocaine, retiling, dalargin, mildronate and lidase into orbital lymphatic area, about 8-10 procedures/course followed by discrete plasmapheresis by activating cell mass due to incubation with mexidole and irradiating with ultraviolet in the course of re-infusion. The innovation provides improved visual functions due to correcting biochemical and microcirculatory disorders. ^ EFFECT: higher efficiency of therapy. ^ 1 cl, 2 ex